XML 25 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Investments
3 Months Ended
Mar. 31, 2026
Investments [Abstract]  
Investments Investments
 
Fixed maturity securities
See Note 6, "Fair Value" for additional fair value disclosures. The following tables summarize the amortized cost and estimated fair value, net of credit loss allowance, of our fixed maturity securities as of:
March 31, 2026
(in thousands)Amortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Available-for-sale securities:
Corporate debt securities
$864,414 $6,444 $9,591 $861,267 
Collateralized debt obligations135,831 99 535 135,395 
Commercial mortgage-backed securities144,079 1,934 1,895 144,118 
Residential mortgage-backed securities209,697 588 11,222 199,063 
Other debt securities35,908 271 359 35,820 
U.S. Treasury11,575 11 102 11,484 
Total available-for-sale securities, net (1)
1,401,504 9,347 23,704 1,387,147 
Held-to-maturity securities - states & political subdivisions4,833 85 4,748 
Total fixed maturity securities, net$1,406,337 $9,347 $23,789 $1,391,895 
(1)This includes an estimated fair value of $37.0 million of securities lent under a securities lending agreement.

December 31, 2025
(in thousands)Amortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Available-for-sale securities:
Corporate debt securities
$834,885 $12,779 $3,185 $844,479 
Collateralized debt obligations133,224 207 164 133,267 
Commercial mortgage-backed securities139,516 2,808 1,783 140,541 
Residential mortgage-backed securities196,624 982 10,380 187,226 
Other debt securities34,863 543 254 35,152 
U.S. Treasury24,116 106 59 24,163 
Total available-for-sale securities, net (1)
1,363,228 17,425 15,825 1,364,828 
Held-to-maturity securities - states & political subdivisions4,833 30 4,863 
Total fixed maturity securities, net$1,368,061 $17,455 $15,825 $1,369,691 
(1)This includes an estimated fair value of $44.4 million of securities lent under a securities lending agreement.


The amortized cost and estimated fair value of our fixed maturity securities at March 31, 2026 are shown below by remaining contractual term to maturity.  Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

March 31, 2026
AmortizedEstimated
(in thousands)costfair value
Available-for-sale securities:
Due in one year or less$54,888 $54,861 
Due after one year through five years588,721 588,118 
Due after five years through ten years205,037 203,455 
Due after ten years552,858 540,713 
Total available-for-sale securities, net (1) (2)
1,401,504 1,387,147 
Held-to-maturity securities - due after ten years4,833 4,748 
Total fixed maturity securities, net$1,406,337 $1,391,895 
(1)The contractual maturities of our available-for-sale securities are included in the table. However, given our intent to sell certain impaired securities, these securities are classified as current assets in our Consolidated Statement of Financial Position at March 31, 2026.
(2)This includes an estimated fair value of $37.0 million of securities lent under a securities lending agreement.
The below securities have been evaluated for credit impairment using criteria described within Note 2, "Significant Accounting Policies, of Notes to Consolidated Financial Statements" included in our Annual Report on Form 10-K for the year ended December 31, 2025 as filed with the SEC on February 23, 2026. The gross unrealized losses are primarily attributable to changes in interest rates and are not deemed to be credit-related. We do not have the intent to sell these securities and it is more likely than not that we would not be required to sell these securities before the anticipated recovery of the amortized cost basis.

The following tables present available-for-sale securities based on length of time in a gross unrealized loss position as of:
March 31, 2026
Less than 12 months12 months or longerTotal
(dollars in thousands)Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
No. of
holdings
Corporate debt securities$404,232 $7,025 $37,403 $2,566 $441,635 $9,591 842 
Collateralized debt obligations89,699 483 3,395 52 93,094 535 128 
Commercial mortgage-backed securities43,321 275 16,736 1,620 60,057 1,895 94 
Residential mortgage-backed securities86,494 848 78,346 10,374 164,840 11,222 176 
Other debt securities14,420 118 3,457 241 17,877 359 40 
U.S. Treasury7,772 102 7,772 102 
Total available-for-sale securities$645,938 $8,851 $139,337 $14,853 $785,275 $23,704 1,282 
Quality breakdown of available-for-sale securities:
Investment grade$533,288 $4,779 $123,311 $12,799 $656,599 $17,578 642 
Non-investment grade112,650 4,072 16,026 2,054 128,676 6,126 640 
Total available-for-sale securities$645,938 $8,851 $139,337 $14,853 $785,275 $23,704 1,282 


December 31, 2025
Less than 12 months12 months or longerTotal
(dollars in thousands)Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
No. of
holdings
Corporate debt securities$72,699 $1,555 $41,040 $1,630 $113,739 $3,185 418 
Collateralized debt obligations57,917 120 3,909 44 61,826 164 83 
Commercial mortgage-backed securities16,103 59 19,956 1,724 36,059 1,783 70 
Residential mortgage-backed securities17,675 27 92,019 10,353 109,694 10,380 146 
Other debt securities3,936 39 3,655 215 7,591 254 27 
U.S. Treasury13,296 59 13,296 59 
Total available-for-sale securities$181,626 $1,859 $160,579 $13,966 $342,205 $15,825 747 
Quality breakdown of available-for-sale securities:
Investment grade$144,472 $433 $144,604 $12,773 $289,076 $13,206 371 
Non-investment grade37,154 1,426 15,975 1,193 53,129 2,619 376 
Total available-for-sale securities$181,626 $1,859 $160,579 $13,966 $342,205 $15,825 747 
Credit loss allowances
The following tables present a roll-forward of the allowances for credit losses on investments for the three months ended March 31:
2026
(in thousands)Available-for-sale securitiesHeld-to-maturity securitiesOther loans receivableAgent loans
Balance, beginning of period$902 $2,167 $15,101 $1,680 
Provision and recoveries275 256 199 
Sales/collections and write-offs(148)
Balance, end of period$1,029 $2,167 $15,357 $1,879 

2025
(in thousands)Available-for-sale securitiesHeld-to-maturity securitiesOther loans receivableAgent loans
Balance, beginning of period$513 $2,167 $12,198 $1,312 
Provision and recoveries365 394 164 
Sales/collections and write-offs(52)
Balance, end of period$826 $2,167 $12,592 $1,476 

Net investment income
Investment income, net of expenses, was generated from the following portfolios for the three months ended March 31:
(in thousands)20262025
Available-for-sale securities$17,232 $13,283 
Equity securities1,307 1,164 
Limited partnerships (1)
732 1,072 
Agent loans1,904 1,444 
Cash equivalents and other2,763 3,387 
Total investment income23,938 20,350 
Less: investment expenses378 402 
Net investment income$23,560 $19,948 
(1)Limited partnership income includes both realized gains (losses) and unrealized valuation changes. Our limited partnership investments are included in the line item "Other assets, net" in the Consolidated Statements of Financial Position. We have made no new significant limited partnership commitments since 2006, and the balance of limited partnership investments is expected to decline over time as additional distributions are received.
Net realized and unrealized investment (losses) gains
Realized and unrealized gains (losses) on investments were as follows for the three months ended March 31:
(in thousands)20262025
Available-for-sale securities:  
Gross realized gains$1,021 $349 
Gross realized losses(872)(611)
Net realized gains (losses) on available-for-sale securities149 (262)
Equity securities(914)759 
Miscellaneous
Net realized and unrealized investment (losses) gains
$(765)$502 


The portion of net unrealized (losses) gains recognized during the reporting period related to equity securities held at the reporting date is calculated as follows for the three months ended March 31:
(in thousands)20262025
Equity securities:
Net (losses) gains recognized during the period
$(914)$759 
Less: net (losses) gains recognized on securities sold
(32)101 
Net unrealized (losses) gains recognized on securities held at reporting date
$(882)$658 


Net impairment (losses) recoveries recognized in earnings
Impairments on investments were as follows for the three months ended March 31:
(in thousands)20262025
Available-for-sale securities:
Intent to sell$10 $
Credit impaired(275)(365)
Total available-for-sale securities(265)(365)
Expected credit losses:
Agent loans(199)(164)
Other loans receivable(212)(385)
Net impairment losses recognized in earnings$(676)$(914)


Securities lending transactions
As of March 31, 2026, the estimated fair value of loaned securities was $55.3 million, consisting of $37.0 million of available- for-sale securities and $18.3 million of equity securities. As of December 31, 2025, the estimated fair value of loaned securities was $64.5 million consisting of $44.4 million of available-for-sale securities and $20.1 million of equity securities. Cash collateral received in connection with these securities lending transactions totaled $49.6 million and $61.9 million as of March 31, 2026 and December 31, 2025 respectively. The cash collateral was reinvested in cash equivalents and is included with "Cash and cash equivalents" in our Consolidated Statements of Financial Position. We also received $8.9 million and $4.5 million of non-cash collateral as of March 31, 2026 and December 31, 2025, respectively, which we are not permitted to sell or repledge. There were no securities lending transactions outstanding with contractual maturities extending beyond one year from the reporting date.

If we have to return cash collateral on short notice, we may have difficulty selling investments in a timely manner, be forced to sell them for less than we otherwise would have been able to realize, or both. In addition, in the event of such forced sale, for securities in an unrealized loss position, realized losses would be incurred on securities sold and impairments would be incurred, if there is a need to sell securities prior to recovery, which may negatively impact our financial condition.